Biomagnetics Enters China Through Joint Venture With ACGT DNA Technologies
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Biomagnetics Diagnostics has entered into a joint venture with DNA sequencing and synthesis firm ACGT DNA Technologies to set up a subsidiary in China to explore the country's biotech diagnostic market
You may also be interested in...
China Expansion: R&D Staffs Growing Rapidly – Shanghai Forum
SHANGHAI - GlaxoSmithKline plans to double its R&D staff in China to roughly 350 by the end of 2009, GlaxoSmithKline China's R&D head of operation management and alliances Carol Zhu said during the ChinaBio Investor Forum 2008
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).